Class IIIOngoingD-0619-2026
Drug recall · July 1, 2026
hydrOXYzine Hydrochloride Oral Solution recall
Why: Presence of foreign substance
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10
- Lots / codes
Lot S25133A
- Quantity
- 6564 bottles
- Company
- ANI Pharmaceuticals, Inc., Baudette, MN
- Distribution
- Nationwide in the USA
- Initiated
- June 2, 2026 · Voluntary: Firm initiated
- Classified
- June 24, 2026
- Reported
- July 1, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydroxyzine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.